Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $167,227 - $208,103
-1,262 Closed
0 $0
Q1 2023

Aug 11, 2023

SELL
$144.61 - $166.54 $6,652 - $7,660
-46 Reduced 3.52%
1,262 $201 Million
Q4 2022

Aug 11, 2023

BUY
$138.31 - $165.87 $180,909 - $216,957
1,308 New
1,308 $211 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hill Investment Group Partners, LLC Portfolio

Follow Hill Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hill Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hill Investment Group Partners, LLC with notifications on news.